Laddar...
Timing of dornase alfa inhalation for cystic fibrosis
BACKGROUND: Inhalation of the enzyme dornase alfa reduces sputum viscosity and improves clinical outcomes of people with cystic fibrosis. This is an update of a previously published Cochrane Review. OBJECTIVES: To determine whether the timing of dornase alfa inhalation (in relation to airway clearan...
Sparad:
| I publikationen: | Cochrane Database Syst Rev |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley & Sons, Ltd
2021
|
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8094131/ https://ncbi.nlm.nih.gov/pubmed/33686652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007923.pub6 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|